D054303Chemicals & DrugsD08.811.913.696.445.308.300.750.187D12.776.964.775.375.545.875D12.776.964.775.375.750.187D12.776.964.775.562.764.875D12.776.964.970.600.850.375.545.875D12.776.964.970.600.850.375.750.187490.994641HIV Reverse TranscriptaseFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson17711379Badri SM, Adeyemi OM, Max BE, Hota BN, Barker DEAIDS patient care and STDsUtility of repeat genotypic resistance testing and clinical response in patients with three class resistance and virologic treatment failure. AIDS Patient Care STDS. 2007 Aug; 21(8):544-50.AIDS Patient Care STDS2007-08-01T00:00:002007Utility of repeat genotypic resistance testing and clinical response in patients with three class resistance and virologic treatment failure.DianaHuangDiana Huang349330Huang, DianaAssistant ProfessorJamesBremerJames W. Bremer349565Bremer, JamesProfessor6Assistant Professor5Associate Professor4Professor12816082Huang DD, Giesler TA, Bremer JWAIDS research and human retrovirusesSequence characterization of the protease and partial reverse transcriptase proteins of the NED panel, an international HIV type 1 subtype reference and standards panel. AIDS Res Hum Retroviruses. 2003 Apr; 19(4):321-8.AIDS Res Hum Retroviruses2003-04-01T00:00:002003Sequence characterization of the protease and partial reverse transcriptase proteins of the NED panel, an international HIV type 1 subtype reference and standards panel.12843074Huang DD, Eshleman SH, Brambilla DJ, Palumbo PE, Bremer JWJournal of clinical microbiologyEvaluation of the editing process in human immunodeficiency virus type 1 genotyping. J Clin Microbiol. 2003 Jul; 41(7):3265-72.J Clin Microbiol2003-07-01T00:00:002003Evaluation of the editing process in human immunodeficiency virus type 1 genotyping.0.5751090.01165364research area of0.2374680.031815510subject area for17166967McNulty A, Jennings C, Bennett D, Fitzgibbon J, Bremer JW, Ussery M, Kalish ML, Heneine W, Garc?a-Lerma JGJournal of clinical microbiologyEvaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing. J Clin Microbiol. 2007 Feb; 45(2):517-21.J Clin Microbiol2006-12-13T00:00:002006Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing.12239297Cohen WM, Bianco A, Connan F, Camoin L, Dalod M, Lauvau G, Ferri?s E, Culmann-Penciolelli B, van Endert PM, Briand JP, Choppin J, Guillet JGJournal of virologyStudy of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1. J Virol. 2002 Oct; 76(20):10219-25.J Virol2002-10-01T00:00:002002Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1.Rush University, Rush Medical CollegeAlanLandayAlan L. Landay41.87386750000000-87.67102690000000349009Landay, AlanProfessorBalaHotaBala Hota41.87644250000000-87.67025950000000349019Hota, BalaAssociate Professortrue1Associate ProfessorAssociate ProfessorInternal Medicine, Division of Geriatrics, Gerontology and Palliative MedicineInternal Medicine, Division of Infectious Diseasestrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessorMicrobial Pathogens and Immunitytrue1ProfessorProfessor